Aimmune’s Peanut Allergy Immunotherapy Brings Safety Concerns To US FDA Panel

 
• By Sue Sutter
Peanut_Butter
Palforzia could be the first oral immunotherapy approved to reduce the incidence and severity of allergic reactions to peanuts. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers